Retraction
Antitumor and Antimetastatic Activities of Docetaxel Are Enhanced by Genistein through Regulation of Osteoprotegerin/Receptor Activator of Nuclear Factor-?B (RANK)/RANK Ligand/MMP-9 Signaling in Prostate Cancer
Paper Information
Record ID:
19204
Journal:
Publication Date:
May 01, 2006
Retraction Date:
September 14, 2018
(7.2 years years ago)
Subjects:
Institutions:
- Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan
- Department of Urology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan
- Department of Internal Medicine, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan
- Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan
Country:
🇺🇸 United StatesArticle Type:
Publisher:
American Association for Cancer Research
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1158/0008-5472.CAN-18-1165Citations (112)
112
Total Citations11
Post-Retraction(9.8%)
79
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
7
After 2+ years
2360
Days since retraction (latest)
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Oct 2013
1780 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Oct 2013
1796 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Aug 2013
1870 days before retraction
Paper citing Downregulation of Notch-1 Contributes to Cell Grow...
Unknown Authors
Unknown Journal
Published: Jul 2013
1892 days before retraction
Paper citing Down-regulation of Apurinic/Apyrimidinic Endonucle...
Unknown Authors
Unknown Journal
Published: Jul 2013
1898 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Apr 2013
1983 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Apr 2013
1992 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Feb 2013
2036 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Feb 2013
2040 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Nov 2012
2143 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Jun 2012
2296 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Apr 2012
2347 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Mar 2012
2382 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Feb 2012
2410 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Jan 2012
2448 days before retraction
(±)Equol inhibits invasion in prostate cancer DU145 cells possibly via down-regulation of matrix metalloproteinase-9, matrix metalloproteinase-2 and urokinase-type plasminogen activator by antioxidant activity
Wei Zheng, Yumei Zhang, Defu Ma et al. (6 authors)
Journal of Clinical Biochemistry and Nutrition
Open Access
Published: Jan 2012
41 citations
41 citations
2448 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Dec 2011
2471 days before retraction
Paper citing Down-regulation of Apurinic/Apyrimidinic Endonucle...
Unknown Authors
Unknown Journal
Published: Oct 2011
2510 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Oct 2011
2538 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Sep 2011
2570 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Aug 2011
2601 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: May 2011
2674 days before retraction
Risks and benefits of dietary isoflavones for cancer
Susanne Andres, Klaus Abraham, Klaus E. Appel et al. (4 authors)
Critical Reviews in Toxicology
Published: Mar 2011
160 citations
160 citations
2729 days before retraction
Tailoring nanostructured solid-lipid carriers for time-controlled intracellular siRNA kinetics to sustain RNAi-mediated chemosensitization
Hui Xue, Ho Lun Wong
Biomaterials
Published: Jan 2011
78 citations
78 citations
2799 days before retraction
Paper citing Down-regulation of Apurinic/Apyrimidinic Endonucle...
Unknown Authors
Unknown Journal
Published: Sep 2010
2913 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Sep 2010
2913 days before retraction
Paper citing Downregulation of Notch-1 Contributes to Cell Grow...
Unknown Authors
Unknown Journal
Published: Jul 2010
2975 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Jul 2010
2997 days before retraction
Paper citing (–)-Epigallocatechin-3-Gallate Prevents Photocarci...
Unknown Authors
Unknown Journal
Published: Jun 2010
3027 days before retraction
Paper citing Downregulation of Notch-1 Contributes to Cell Grow...
Unknown Authors
Unknown Journal
Published: Jun 2010
3027 days before retraction
Paper citing Human a1 type IV collagen NC1 domain exhibits dist...
Unknown Authors
Unknown Journal
Published: Apr 2010
3079 days before retraction
Paper citing Apoptosis-Inducing Effect of Erlotinib Is Potentia...
Unknown Authors
Unknown Journal
Published: Apr 2010
3088 days before retraction
Paper citing Apoptosis-Inducing Effect of Erlotinib Is Potentia...
Unknown Authors
Unknown Journal
Published: Feb 2010
3134 days before retraction
Paper citing Apoptosis-Inducing Effect of Erlotinib Is Potentia...
Unknown Authors
Unknown Journal
Published: Aug 2009
3320 days before retraction
Paper citing (–)-Epigallocatechin-3-Gallate Prevents Photocarci...
Unknown Authors
Unknown Journal
Published: Jun 2009
3392 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Apr 2009
3446 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Mar 2009
3484 days before retraction
Paper citing Regulation of cyclooxygenase-2 mRNA stability by t...
Unknown Authors
Unknown Journal
Published: Dec 2008
3562 days before retraction
Paper citing Down-regulation of Apurinic/Apyrimidinic Endonucle...
Unknown Authors
Unknown Journal
Published: Oct 2008
3635 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Sep 2008
3665 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Sep 2008
3665 days before retraction
Diagnostic and prognostic role of matrix metalloproteases in cancer
Pia Vihinen, Risto Ala‐aho, Veli‐Matti Kähäri
Expert Opinion on Medical Diagnostics
Published: Sep 2008
3 citations
3 citations
3665 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Jul 2008
3704 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Jun 2008
3757 days before retraction
Paper citing RNAi-mediated inhibition of cathepsin B and uPAR l...
Unknown Authors
Unknown Journal
Published: Jun 2008
3757 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Apr 2008
3809 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Mar 2008
3849 days before retraction
Paper citing Growth Inhibitory and Antimetastatic Effect of Gre...
Unknown Authors
Unknown Journal
Published: Mar 2008
3849 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Feb 2008
3875 days before retraction
Paper citing Antitumor and Antimetastatic Activities of Docetax...
Unknown Authors
Unknown Journal
Published: Nov 2007
3964 days before retraction
Quick Stats
Total Citations:
112
Years Since Retraction:
7.2 years
Open Access:
Yes
Last Checked:
Never